4
Changes in Ownership
Trevi Therapeutics, Inc. Filed Acc 0000950170-24-016460
Options or other derivatives
- Chief Scientific Officer acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
SCIASCIA THOMAS · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-15 | Grant or award : show line 1 in the form Stock Option (right to buy) | +150,000 | 150,000 | D |
Loading xslF345X05/ownership.xml…